NCT06681337View on ClinicalTrials.gov

Universal CAR-T Cell Therapy for Refractory Lupus Nephritis

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 25, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Lupus Nephritis
Interventions
BIOLOGICAL

BCMA CART + CD19 CART

BCMA CART + CD19 CART

Sponsors
All Listed Sponsors
collaborator

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

OTHER

lead

Bioray Laboratories

INDUSTRY